I own a considerable number of shares in Avita and anticipate the company will flourish as the technology gains wider, multi-purpose useage.
But for the life of me I can not understand, at this stage of the company's progression, how the CEO is remunerated to the tune of $25m/yr. He came late to the party and is just exploiting what can only be perceived as a very pliable board.
CEO's in recent years bamboozle boards and markets that they are indispensable to their company's prospects; they aren't.
Surely Avita can replace Perry with someone who is prepared to accept a more responsibly structured remuneration package and is not so willing to torpedo the share price on a regular basis.
The science, the product, the marketing and sales folks and its wider acceptance as the standard-of-care for certain burns and ailments will take care of everything else.
- Forums
- ASX - By Stock
- AVH
- Ann: Change of Director's Interest Notice - Michael Perry
Ann: Change of Director's Interest Notice - Michael Perry, page-25
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.76 |
Change
0.130(4.94%) |
Mkt cap ! $187.9M |
Open | High | Low | Value | Volume |
$2.74 | $2.77 | $2.66 | $1.044M | 382.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 980 | $2.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.76 | 10173 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 980 | 2.740 |
3 | 36189 | 2.700 |
1 | 10000 | 2.680 |
3 | 2022 | 2.630 |
1 | 2671 | 2.620 |
Price($) | Vol. | No. |
---|---|---|
2.760 | 10173 | 2 |
2.770 | 17029 | 3 |
2.780 | 1500 | 1 |
2.790 | 3162 | 1 |
2.800 | 2372 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online